Skip to main content
logo
Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
23.65
-0.27 (-1.13%)
May 20, 2026, 11:45 AM CST

Hybio Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
21,12715,81011,38511,99415,52711,138
Market Cap Growth
86.15%38.87%-5.08%-22.75%39.41%88.22%
Enterprise Value
22,99317,61613,12213,71017,02412,784
Last Close Price
23.9217.9012.8913.5817.5812.61
PE Ratio
233.88432.32---361.52
Forward PE
-9.219.219.219.219.21
PS Ratio
22.1116.3619.2927.8022.0515.13
PB Ratio
27.9025.1019.0715.3111.976.76
P/TBV Ratio
52.2045.0339.9222.3715.448.43
P/FCF Ratio
--232.96---
P/OCF Ratio
80.0567.5969.12-982.2871.02
PEG Ratio
-0.730.730.730.730.73
EV/Sales Ratio
24.0618.2322.2331.7824.1717.37
EV/EBITDA Ratio
65.3650.27115.59---
EV/EBIT Ratio
102.2480.61----
EV/FCF Ratio
-1650.36-268.51---
Debt / Equity Ratio
2.583.033.012.591.391.09
Debt / EBITDA Ratio
5.445.4315.72---
Debt / FCF Ratio
--36.79---
Net Debt / Equity Ratio
2.442.872.852.151.190.71
Net Debt / EBITDA Ratio
5.155.1514.99-7.57-29.27-8.09
Net Debt / FCF Ratio
-132.58-4012.7434.83-19.76-8.85-27.80
Asset Turnover
0.300.310.190.130.190.19
Inventory Turnover
1.351.611.441.521.121.58
Quick Ratio
0.190.140.140.360.521.28
Current Ratio
0.430.290.330.480.711.55
Return on Equity (ROE)
12.92%5.55%-26.10%-49.56%-25.30%1.71%
Return on Assets (ROA)
4.49%4.43%-0.64%-6.74%-3.03%-4.26%
Return on Invested Capital (ROIC)
6.73%4.89%-1.36%-14.00%-6.44%-7.61%
Return on Capital Employed (ROCE)
12.60%15.90%-2.00%-20.00%-7.40%-8.50%
Earnings Yield
0.45%0.23%-1.52%-4.28%-2.39%0.28%
FCF Yield
-0.07%-0.00%0.43%-0.71%-1.12%-0.38%
Payout Ratio
102.92%259.33%---375.37%
Buyback Yield / Dilution
-1.52%-5.29%2.00%-0.42%14.09%-11.21%
Total Shareholder Return
-1.52%-5.29%2.00%-0.42%14.09%-11.21%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.